
CorMedix Inc
NASDAQ:CRMD

Intrinsic Value
The intrinsic value of one
CRMD
stock under the Base Case scenario is
31.9
USD.
Compared to the current market price of 9.38 USD,
CorMedix Inc
is
Undervalued by 71%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
CorMedix Inc
Fundamental Analysis

Revenue & Expenses Breakdown
CorMedix Inc
Balance Sheet Decomposition
CorMedix Inc
Current Assets | 114.6m |
Cash & Short-Term Investments | 51.7m |
Receivables | 51.7m |
Other Current Assets | 11.2m |
Non-Current Assets | 4.3m |
PP&E | 2.3m |
Intangibles | 1.8m |
Other Non-Current Assets | 105.4k |
Free Cash Flow Analysis
CorMedix Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
CorMedix Inc
Revenue
|
43.5m
USD
|
Cost of Revenue
|
-3.2m
USD
|
Gross Profit
|
40.3m
USD
|
Operating Expenses
|
-62.6m
USD
|
Operating Income
|
-22.4m
USD
|
Other Expenses
|
4.4m
USD
|
Net Income
|
-17.9m
USD
|
CRMD Profitability Score
Profitability Due Diligence
CorMedix Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Score
CorMedix Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
CRMD Solvency Score
Solvency Due Diligence
CorMedix Inc's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Score
CorMedix Inc's solvency score is 66/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CRMD Price Targets Summary
CorMedix Inc
According to Wall Street analysts, the average 1-year price target for
CRMD
is 15.81 USD
with a low forecast of 12.12 USD and a high forecast of 19.95 USD.
Dividends
Current shareholder yield for CRMD is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CRMD
stock under the Base Case scenario is
31.9
USD.
Compared to the current market price of 9.38 USD,
CorMedix Inc
is
Undervalued by 71%.